(Press-News.org) DURHAM, N.C.— The first trial to study patients with acute coronary syndrome who do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs – prasugrel and clopidogrel – in preventing the first occurrence of death, heart attack or stroke, according to Duke University Medical Center cardiologists.
The study also showed no difference in serious bleeding complications.
At the same time, the Duke researchers observed an unexpected reduction in heart attack, stroke and death among patients treated with prasurgrel beyond one year of treatment. The researchers say this potential time-dependent benefit requires further exploration.
The results were presented by the Duke researchers at the European Society of Cardiology Scientific Sessions in Munich, Germany today, and published online in the New England Journal of Medicine.
"If you look at this study as a comparison of two drugs, it doesn't tell the whole story," says E. Magnus Ohman, M.D., a professor of medicine at Duke and chairman of the TRILOGY ACS study. "This is a unique patient population that has never before been studied."
Acute coronary syndrome (ACS) refer to a group of conditions that include heart attacks and chest pain caused by clogged coronary arteries. To date, most trials evaluating anti-clotting drugs for ACS patients have focused on patients who undergo revascularization procedures such as stent implantation with percutaneous coronary intervention and coronary artery bypass surgery to restore blood flow.
Up to 60 percent of ACS patients worldwide undergo revascularization procedures according to published data. The remaining 40 percent are managed solely with drug therapy. These patients are at higher risk for repeated cardiovascular-related events, such as heart attack, stroke, and death.
"Optimizing medical therapy for these patients is extremely important," Ohman says.
Prasugrel and clopidogrel are members of the thienopyridine class of adenosine diphosphate receptor inhibitors that prevent the formation of blood clots in arteries by binding to specific receptors and inhibiting the clumping of platelets.
The efficacy and safety of the two drugs were first compared in a Phase III trial called TRITON that evaluated 13,608 ACS patients who planned to undergo stent implantation. The TRITON study, published in 2007, found that 10 mg of prasugrel was 19 percent more effective in preventing cardiovascular death, nonfatal heart attacks and strokes than clopidogrel. It also found prasurgrel caused a higher incidence of fatal bleeding.
TRILOGY ACS is a Phase III, double-blind, randomized trial that was developed as a follow-up to the TRITON trial.
"We designed our study to see if prasugrel was just as effective in patients who aren't getting coronary stents or coronary bypass surgery," says Ohman.
TRILOGY ACS enrolled 9,326 participants at 966 sites in 52 countries. It compared up to 2.5 years of treatment with prasugrel 10 mg daily vs. clopidogrel 75 mg daily, both in combination with aspirin, in ACS patients who were younger than age 75 years. The prasugrel dose was reduced to 5 mg daily for patients weighing less than 60 kilograms. A secondary analysis also looked at patients who were age 75 years or older who received 5 mg of prasurgrel daily vs. clopidogrel 75 mg daily because TRITON demonstrated an increased risk of major bleeding in these patients when they were treated with prasugrel 10mg daily.
After a median of 17 months of follow up, the primary end point - described as the time to first occurrence of death, heart attack or stoke - occurred in 13.9 percent of patients under age 75 years vs. 16.0 percent of those treated with clopidogrel. This is considered a non-significant difference.
However, a lower risk of recurrent adverse events with prasugrel was observed after 12 months of treatment. "This finding has not been observed in previous studies such as TRITON that evaluated a shorter duration of treatment," said Dr. Ohman. "We believe further exploration of this finding is needed."
The researchers did not observe an increase in severe or life-threatening bleeding complications with prasugrel as seen in the TRITON study. "Because we modified the prasugrel dose for patients with a higher risk of bleeding, we observed that prasugrel is as safe as clopidogrel with long-term treatment," said Dr. Ohman.
### Funding: TRILOGY ACS is sponsored by Eli Lilly and Company, and Daiichi Sankyo Co.
Disclosures: Co-authors Drs. E. Magnus Ohman and Matthew Roe report receiving research support and research grants from Eli Lilly & Company, Daiichi Sankyo and other sources. A complete list of all author disclosures is contained in the manuscript.
Anti-clotting drugs yield similar results
Potential long-term benefit observed for first time in ACS patients
2012-08-26
ELSE PRESS RELEASES FROM THIS DATE:
Diagnostic test shows potential to noninvasively identify significant coronary artery disease
2012-08-26
CHICAGO – Among patients with suspected or known coronary artery disease, use of a method that applies computational fluid dynamics to derive certain data from computed tomographic (CT) angiography demonstrated improved diagnostic accuracy vs. CT angiography alone for the diagnosis of ischemia, according to a study being published online by JAMA. The study is being released early to coincide with its presentation at the European Society of Cardiology Congress.
"Coronary computed tomographic angiography is a noninvasive anatomic test for diagnosis of coronary stenosis ...
Garvey Schubert Barer Adds Tax Attorney Jonathan Cavanagh
2012-08-26
Garvey Schubert Barer added Jonathan Cavanagh as an associate in its Tax and Benefits Group.
"Jonathan is a great addition to our firm. His significant experience in public accounting and his deep understanding of the financial and tax implications of business decisions will be a tremendous asset to our clients," said Anne Preston, chair of Garvey Schubert Barer.
Most recently with Thornton Byron LLP, Cavanagh represents clients in tax controversy matters before the Internal Revenue Service and state taxing authorities. During law school, he served as a ...
Stickman Stew Announces Appointment of Invurgency To Manage Manufacturing and Component Sourcing
2012-08-26
Jane Guinn, President and Creator of Stickman Stew Thematic Characters announced today that her Toy and Gift design atelier has engaged the services of Invergency llc to manage the manufacturing of her group's products for a scheduled retail introduction in Spring-2013.
"Together with my Managing Consultants at Duquesa Marketing we selected Invergency from a robust field of candidates", said Mrs. Guinn. "We were looking for a vendor with deep experience in both the Toy and Gift spaces, an unusual combination. Rick Harrington and his Invergency team offer ...
Divorce and Property Division When a Spouse Is in the Military
2012-08-26
Divorce and Property Division When a Spouse Is in the Military
As the U.S. military presence in Iraq and Afghanistan continues, many military families feel the pressures associated with having loved ones overseas on tours of duty. Frequently, people find they cannot take the strain and decide to divorce. The divorce rate among military families has been on the rise for over a decade. According to the Department of Defense, almost 30,000 military marriages ended in 2011 -- the highest military divorce rate since 1999. Military members or spouses considering divorce should ...
Florida Woman Appealing 20-Year Sentence for Firing a Gun at Her Husband
2012-08-26
Florida Woman Appealing 20-Year Sentence for Firing a Gun at Her Husband
On August 27, 2012, supporters of a Florida woman convicted of aggravated assault with a deadly weapon held a rally to draw attention to her situation. The woman, currently serving a 20-year prison sentence, is appealing her conviction because she claims that she fired a gun at her husband in self defense. The woman had no previous criminal record. However, Florida's strict "10-20-Life" law caused the woman to receive a stiff penalty.
Claims of Domestic Abuse
The conviction stems ...
Florida State Football Player Jailed for Violating Probation
2012-08-26
Florida State Football Player Jailed for Violating Probation
In June 2012, a Florida State University tailback was arrested for violating the terms of his probation after he failed a Breathalyzer test. The football player's arrest shows how serious a probation violation can be in Florida. Anyone on probation or facing probation in Florida should be aware of the restrictions that may be placed on them under the state's laws
Football Player Violated Probation
On April 4, 2012, the football player received a sentence that included six months of probation after pleading ...
Popular eLearning Platform Hits Schools Near You
2012-08-26
Novachi Classroom Collaboration (NCC) continues its rapid growth as it spreads like wildfire throughout Florida and the rest of the United States. The application, designed specifically to provide a safe and secure environment for schools to go about the business of teaching and learning online, is seeing its first real test this month as schools all over the country begin the Fall session.
NCC has become popular with teachers in part because it's free, but also due to the ease-of-use and flexibility the platform provides. From sign-up to setup, teachers will find they ...
Walsh Family Media and Still Hip Promotions Sign Strategic Partnership
2012-08-26
Walsh Family Media, LLC (WFM) ups the ante in the family entertainment universe by signing a multi-year non-exclusive deal with Still Hip LLC, producers of the Hip Tot Music Fest. The strategic partnership injects a cartoon element into the festival and brings The Cool Beans animated band to the live stage.
Upon learning of The Cool Beans phenomenon Hip Tot co-creator Gabby Nap said, "our audience of 200 plus will be blown away each time they see The Cool Beans jump off the screen and into The Hip Tot spotlight." Gabby and I knew we had to join forces with ...
FRANdex Registered a Positive Gain in the 2nd Quarter
2012-08-26
Franchise companies continue to outperform the general market, according to FRANdex tracking results released today by FRANdata, an independent company that tracks and analyzes franchises and their performance.
The market gave up much of the gains achieved in the first quarter with S&P and Russell falling 3% and 4%, respectively, compared to the previous quarter. Continuing to perform well was FRANdex, the index tracking publicly-traded franchise companies, which outperformed the broader indices registering a 2% increase. This marks the third consecutive quarter ...
Stateland Brown Renews Lease, Expands at Fountains Center in Boca Raton
2012-08-26
The building at 7300 West Camino Real within the Fountains Center office and retail park is 100 percent leased following a lease renewal and expansion for commercial real estate brokerage firm Stateland Brown LLC. Fountains Center has been the home of Stateland Brown since 2009.
Stateland Brown has over 13 years of experience investing, selling, developing and managing real estate in the state of Florida. According to owner and broker Dan Statlander, the company has experienced overwhelming success and he decided to expand the space to accommodate the growing staff.
With ...
LAST 30 PRESS RELEASES:
Forging a novel therapeutic path for patients with Rett Syndrome using AI
Global drought hotspots report catalogs severe suffering, economic damage in 2023-2025
Study: To battle tip fatigue, businesses should make their service efforts visible
This spongy material and the sun’s power remove salt from seawater
Nearly 1 in 6 older adults take aspirin despite no history of heart disease
ACMG takes action to address national gap in newborn screening leadership
Stopping pancreatic cancer spread using benzaldehyde
Pusan National University study reveals engineered bacterial vesicles to combat antimicrobial resistance
Africa needs more large firms, not more entrepreneurs, for economic growth
Clues in the claws: finger length may reveal sexual preferences in rats
World-unique method enables simulation of error-correctable quantum computers
Scientists uncover immune cells that help prostate cancer resist treatment — and reveal a way to stop them
Cellulose instead of crude oil: team with participation of Graz University of Technology develops sustainable foams
New fossils from Earth’s most famous extinction show climate tipping point was crossed
AI predicts patients likely to die of sudden cardiac arrest
Double detonation: New image shows remains of star destroyed by pair of explosions
Gene therapy restored hearing in deaf patients
Survey finds Trump losing favor, Newsom gaining
Religion, politics and war drive urban wildlife evolution
Peeking inside AI brains: Machines learn like us
A map for single-atom catalysts
What about tritiated water release from Fukushima? Ocean model simulations provide an objective scientific knowledge on the long-term tritium distribution
Growing crisis of communicable disease in Canada in tandem with US cuts
Women get better at managing their anger as they age
Illegal shark product trade evident in Australia and New Zealand
New search tool brings 21% better accuracy for robotics developers
New model extracts sentence-level proof to verify events, boosting fact-checking accuracy for journalists, legal teams, and policymakers
Efficient carbon integration of CO₂ in propane aromatization over acidic zeolites
FPGA-accelerated AI for demultiplexing multimode fiber towards next-generation communications
Vitamin D3 nanoemulsion significantly improves core symptoms in children with autism: A clinical trial
[Press-News.org] Anti-clotting drugs yield similar resultsPotential long-term benefit observed for first time in ACS patients